Quick Answer
VERTEX PHARMACEUTICALS INC / MA reported Common Stock Shares Outstanding of 253.99 million shares for the year ending 2025.
- VERTEX PHARMACEUTICALS INC / MA showed a decrease of -1.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from VERTEX PHARMACEUTICALS INC / MA's annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), VERTEX PHARMACEUTICALS INC / MA's Common Stock Shares Outstanding has grown by 27.0%.
- Historical annual values: Fiscal year 2025: 253.99 million shares | Fiscal year 2024: 256.94 million shares | Fiscal year 2023: 257.70 million shares | Fiscal year 2022: 257.01 million shares | Fiscal year 2021: 254.48 million shares | Fiscal year 2020: 259.89 million shares | Fiscal year 2019: 258.99 million shares | Fiscal year 2018: 255.17 million shares | Fiscal year 2017: 253.25 million shares | Fiscal year 2016: 248.30 million shares | Fiscal year 2015: 246.31 million shares | Fiscal year 2014: 241.76 million shares | Fiscal year 2013: 233.79 million shares | Fiscal year 2012: 217.29 million shares | Fiscal year 2011: 209.30 million shares | Fiscal year 2010: 203.52 million shares | Fiscal year 2009: 199.96 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: